0001127602-18-036235.txt : 20181213 0001127602-18-036235.hdr.sgml : 20181213 20181213183033 ACCESSION NUMBER: 0001127602-18-036235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181212 FILED AS OF DATE: 20181213 DATE AS OF CHANGE: 20181213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANSTICE DAVID W CENTRAL INDEX KEY: 0001181171 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 181234207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-12-12 0001520262 Alkermes plc. ALKS 0001181171 ANSTICE DAVID W CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 Ordinary Shares 2018-12-12 4 M 0 15000 8.98 A 70000 D Ordinary Shares 2018-12-12 4 S 0 3552 35.608 D 66448 D Ordinary Shares 2018-12-12 4 S 0 235 35.9218 D 66213 D Ordinary Shares 2018-12-12 4 M 0 5000 8.98 A 71213 D Ordinary Shares 2018-12-12 4 S 0 5000 35.5578 D 66213 D Non Qualified Stock Option (Right to Buy) 8.98 2018-12-12 4 M 0 15000 0 D 2019-10-06 Ordinary Shares 15000 5000 D Non Qualified Stock Option (Right to Buy) 8.98 2018-12-12 4 M 0 5000 0 D 2019-10-06 Ordinary Shares 5000 0 D The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.885 to $35.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.88 to $35.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.87 to $35.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Jennifer Baptiste, attorney-in-fact for David W. Anstice 2018-12-13